Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)
- 25 July 2023
- journal article
- review article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 27 (4) , 614-622
Abstract
Introduction Focal therapy (FT) is a promising alternative with curative intent for Low- to Intermediate-risk localized Prostate Cancer (PCa), claiming better functional outcomes and safety profile than standard whole-gland treatments. Ten different FT modalities have been described in the literature. The objective of our narrative review is to evaluate the safety profile and functional outcomes of these different modalities and the current most used tools of assessment for those outcomes. Material and methods Literature search was performed on 21st February 2023 using PubMed, EMBASE, and Scopus, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA). Articles reporting whole-gland treatments were excluded. All articles reporting functional outcomes were included. Results One-hundred-seven studies, reporting data on 6933 patients, were included (26 on High Intensity Focal Ultrasound, 22 on Focal Cryotherapy, 14 on Irreversible Electroporation, 11 on Focal brachytherapy, 10 on Focal Laser Ablation, 8 on Photodynamic Therapy, 3 on Microwave ablation, 3 on Robotic Partial Prostatectomy, 2 on bipolar Radio Frequency Ablation, 1 on Prostatic Artery Embolization, and 7 studies comparing different FTs). Post-operative pad-free rate ranged between 92.3–100%. Greater heterogeneity exists considering the Change in Erectile Function, with Changing in Erectile function- rates ranging between 0–94.4% (Cryotherapy). The most used Patient-Reported Outcome Measures (PROMs) were the International Prostate Symptom Score and the International Index of Erectile Function for incontinence/urinary function and potency, respectively. The most common reported complications were hematuria, infections, and urethral strictures, with rates widely ranging among different treatments. The Clavien–Dindo Classification was the most used (40/88 papers) to describe adverse events. Conclusion FT is a promising treatment for localized PCa, achieving excellent results in terms of safety and functional outcomes. There is a wide heterogeneity in the definition of PROMS and time of collection between studies. High quality comparative studies with standard treatments are needed to reinforce these findings.Keywords
This publication has 57 references indexed in Scilit:
- Morbidity of Focal Therapy in the Treatment of Localized Prostate CancerEuropean Urology, 2013
- Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications RateAdvances in Urology, 2012
- Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) RegistryBJU International, 2011
- Pentafecta: A New Concept for Reporting Outcomes of Robot-Assisted Laparoscopic Radical ProstatectomyEuropean Urology, 2011
- The Index Lesion and the Origin of Prostate CancerNew England Journal of Medicine, 2009
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer SurvivorsNew England Journal of Medicine, 2008
- Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function (“trifecta”)Urology, 2005
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005
- Radiofrequency tumor ablation: principles and techniquesEuropean Journal of Ultrasound, 2001